{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27558678", "DateCompleted": {"Year": "2017", "Month": "02", "Day": "09"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "07"}, "Article": {"ArticleDate": [], "ELocationID": [], "Language": ["eng"], "Journal": {"ISSN": "1873-4294", "JournalIssue": {"Volume": "17", "Issue": "4", "PubDate": {"Year": "2017"}}, "Title": "Current topics in medicinal chemistry", "ISOAbbreviation": "Curr Top Med Chem"}, "ArticleTitle": "Heterocyclic Compounds: Effective \u03b1-Amylase and \u03b1-Glucosidase Inhibitors.", "Pagination": {"StartPage": "428", "EndPage": "440", "MedlinePgn": "428-440"}, "Abstract": {"AbstractText": ["Diabetes Mellitus (DM) is a metabolic disease characterized by high blood sugar levels. Recently, it has emerged as an important and global health problem with long-term complications and high economic burden. \u03b1-Amylase (\u03b1-Amy) and \u03b1-glucosidase (\u03b1-Gls) are two enzymes which are involved in the hydrolysis of starch into sugars and disaccharides leading to the increase of blood glucose level. Hence, inhibition of \u03b1-amylase and \u03b1-glucosidase plays key role in the treatment of type 2 diabetes. Heterocyclic compounds -both synthetic and naturally occurring derivatives- possess efficient biological properties. At this juncture, they have demonstrated potent inhibitory activity against \u03b1-Amy and \u03b1-Gls and were found to be versatile tools for the development of novel anti-diabetic agents."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Saeedi", "ForeName": "Mina", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Hadjiakhondi", "ForeName": "Abbas", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Nabavi", "ForeName": "Seyed Mohammad", "Initials": "SM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Manayi", "ForeName": "Azadeh", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Curr Top Med Chem", "NlmUniqueID": "101119673", "ISSNLinking": "1568-0266"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycoside Hydrolase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Heterocyclic Compounds"}, {"RegistryNumber": "EC 3.2.1.1", "NameOfSubstance": "alpha-Amylases"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Glycoside Hydrolase Inhibitors"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Heterocyclic Compounds"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "alpha-Amylases"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2015", "Month": "11", "Day": "3"}, {"Year": "2015", "Month": "1", "Day": "22"}, {"Year": "2016", "Month": "2", "Day": "13"}, {"Year": "2016", "Month": "8", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "8", "Day": "26", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27558678", "10.2174/1568026616666160824104655", "CTMC-EPUB-77967"]}}], "PubmedBookArticle": []}